# Beckley Psytech

its BPL-003 intranasal 5-MeO-DMT formulation reported positive Phase IIa topline data in May 2025 showing durable efficacy up to three months in treatment-resistant depression from a single dose, with a session substantially shorter than a multi-hour psilocybin trip;…

Source: https://en.bioecon.ru/companies/beckley-psytech/
Updated: 2026-08-15

- Country: United Kingdom

## Technologies

- [Psychedelic medicine & neuropsychiatric biologics](https://en.bioecon.ru/technology/psychedelic-medicine-neuropsychiatric-biologics/)